BCL2 and leukemia: The high expression of BCL2 and BAX suggests that this otherwise refractory subgroup might display a particular sensitivity to targeted therapy with BH3 mimetics, i.e. BCL-2 bound BAX might act as a suicide bag in this particular type of leukemia.